JP2016146837A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016146837A5 JP2016146837A5 JP2016041230A JP2016041230A JP2016146837A5 JP 2016146837 A5 JP2016146837 A5 JP 2016146837A5 JP 2016041230 A JP2016041230 A JP 2016041230A JP 2016041230 A JP2016041230 A JP 2016041230A JP 2016146837 A5 JP2016146837 A5 JP 2016146837A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- recombinant adenovirus
- protein
- recombinant
- immunogenic epitope
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000701161 unidentified adenovirus Species 0.000 claims 14
- 230000002163 immunogen Effects 0.000 claims 10
- 201000004792 malaria Diseases 0.000 claims 9
- 108090000623 proteins and genes Proteins 0.000 claims 9
- 210000003046 sporozoite Anatomy 0.000 claims 8
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 claims 7
- 239000002773 nucleotide Substances 0.000 claims 7
- 125000003729 nucleotide group Chemical group 0.000 claims 7
- 244000045947 parasite Species 0.000 claims 7
- 102000004169 proteins and genes Human genes 0.000 claims 7
- 108091007491 NSP3 Papain-like protease domains Proteins 0.000 claims 6
- 210000001744 T-lymphocyte Anatomy 0.000 claims 5
- KQPKMEYBZUPZGK-UHFFFAOYSA-N 4-[(4-azido-2-nitroanilino)methyl]-5-(hydroxymethyl)-2-methylpyridin-3-ol Chemical compound CC1=NC=C(CO)C(CNC=2C(=CC(=CC=2)N=[N+]=[N-])[N+]([O-])=O)=C1O KQPKMEYBZUPZGK-UHFFFAOYSA-N 0.000 claims 4
- 101001111984 Homo sapiens N-acylneuraminate-9-phosphatase Proteins 0.000 claims 4
- 102100023906 N-acylneuraminate-9-phosphatase Human genes 0.000 claims 4
- 108090000565 Capsid Proteins Proteins 0.000 claims 3
- 102100023321 Ceruloplasmin Human genes 0.000 claims 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 241000223960 Plasmodium falciparum Species 0.000 claims 2
- 101710143509 Pre-histone-like nucleoprotein Proteins 0.000 claims 2
- 239000000427 antigen Substances 0.000 claims 2
- 108091007433 antigens Proteins 0.000 claims 2
- 102000036639 antigens Human genes 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 229960005486 vaccine Drugs 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 101710132601 Capsid protein Proteins 0.000 claims 1
- 108020004705 Codon Proteins 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 210000003719 b-lymphocyte Anatomy 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| USPCT/US2009/054212 | 2009-08-18 | ||
| PCT/US2009/054212 WO2011022002A1 (en) | 2009-08-18 | 2009-08-18 | Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012525677A Division JP5947719B2 (ja) | 2009-08-18 | 2010-08-18 | 免疫原性マラリア原虫周辺スポロゾイトタンパク質エピトープによる組換えアデノウイルスの改変 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016146837A JP2016146837A (ja) | 2016-08-18 |
| JP2016146837A5 true JP2016146837A5 (enExample) | 2017-02-16 |
| JP6293181B2 JP6293181B2 (ja) | 2018-03-14 |
Family
ID=43607237
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012525677A Expired - Fee Related JP5947719B2 (ja) | 2009-08-18 | 2010-08-18 | 免疫原性マラリア原虫周辺スポロゾイトタンパク質エピトープによる組換えアデノウイルスの改変 |
| JP2016041230A Expired - Fee Related JP6293181B2 (ja) | 2009-08-18 | 2016-03-03 | 免疫原性マラリア原虫周辺スポロゾイトタンパク質エピトープによる組換えアデノウイルスの改変 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012525677A Expired - Fee Related JP5947719B2 (ja) | 2009-08-18 | 2010-08-18 | 免疫原性マラリア原虫周辺スポロゾイトタンパク質エピトープによる組換えアデノウイルスの改変 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20170348405A1 (enExample) |
| EP (2) | EP2467157A4 (enExample) |
| JP (2) | JP5947719B2 (enExample) |
| KR (1) | KR20120094469A (enExample) |
| CN (2) | CN103025349B (enExample) |
| BR (1) | BR112012003808A2 (enExample) |
| CA (1) | CA2769415A1 (enExample) |
| IL (1) | IL217709A (enExample) |
| MX (1) | MX339830B (enExample) |
| NZ (1) | NZ598703A (enExample) |
| PH (1) | PH12012500164A1 (enExample) |
| RU (1) | RU2585228C2 (enExample) |
| SG (2) | SG10201404970PA (enExample) |
| UA (1) | UA108081C2 (enExample) |
| WO (2) | WO2011022002A1 (enExample) |
| ZA (1) | ZA201201286B (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012154199A1 (en) | 2010-10-18 | 2012-11-15 | The Government Of The United States, As Represented By The Secretary Of The Army | Soluble recombinant plasmodium falciparum circumsporozoite protein |
| US20120244178A1 (en) * | 2011-03-25 | 2012-09-27 | Denise Doolan | Plasmodium falciparum antigens |
| CA2903582C (en) | 2013-03-14 | 2021-06-08 | Salk Institute For Biological Studies | Oncolytic adenovirus compositions |
| AU2014275772B2 (en) * | 2013-06-03 | 2020-01-02 | Vlp Therapeutics, Inc. | Malaria vaccine |
| JP6934862B2 (ja) * | 2015-09-16 | 2021-09-15 | アーティフィシャル セル テクノロジーズ インコーポレイテッド | 抗マラリア組成物および方法 |
| DK3405582T3 (da) * | 2016-01-21 | 2020-11-02 | Janssen Vaccines & Prevention Bv | Forbedret adenovirusbaseret malaria-vaccine, der koder for og fremviser et malaria-antigen |
| JP7015551B2 (ja) | 2016-02-23 | 2022-02-15 | ソーク インスティテュート フォー バイオロジカル スタディーズ | ウイルス動態への影響を最小限にするための治療用アデノウイルスにおける外因性遺伝子発現 |
| WO2017147265A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | High throughput assay for measuring adenovirus replication kinetics |
| CN107841513B (zh) * | 2016-09-18 | 2023-04-14 | 中国科学院上海巴斯德研究所 | 基于M2e表位的广谱型流感疫苗 |
| CA3045892A1 (en) | 2016-12-12 | 2018-06-21 | Salk Institute For Biological Studies | Tumor-targeting synthetic adenoviruses and uses thereof |
| CN108192876A (zh) * | 2017-12-07 | 2018-06-22 | 东莞市第八人民医院 | 一种人3型腺病毒衣壳蛋白同时展示ca16双中和抗原表位疫苗候选株的制备方法和应用 |
| BR112020019942A2 (pt) | 2018-04-09 | 2021-01-26 | Salk Institute For Biological Studies | composições de adenovírus oncolítico com propriedades de replicação aprimoradas |
| WO2020221451A1 (en) * | 2019-04-30 | 2020-11-05 | Humabs Biomed Sa | Antibodies binding to plasmodium circumsporozoite protein and uses thereof |
| CN110687289B (zh) * | 2019-10-17 | 2023-04-18 | 中国人民解放军陆军军医大学 | Fgl2蛋白作为疟疾感染标志物的应用 |
| GB201915905D0 (en) * | 2019-11-01 | 2019-12-18 | Spybiotech Ltd | Viruses with modified capsid proteins |
| JP2021178021A (ja) * | 2020-05-14 | 2021-11-18 | 株式会社三洋物産 | 遊技機 |
| US20240240203A1 (en) * | 2021-05-04 | 2024-07-18 | SpyBiotech Limited | Adenoviral vectors and vaccines thereof |
| EP4404947A4 (en) * | 2021-09-23 | 2025-12-10 | Sagittarius Bio Inc | Adenovirus and Methods of Using Adenovirus |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6066623A (en) * | 1993-11-23 | 2000-05-23 | The United States Of America As Represented By The Secretary Of The Navy | Polynucleotide vaccine protective against malaria, methods of protection and vector for delivering polynucleotide vaccines |
| CA2453880A1 (en) * | 2001-07-25 | 2003-02-06 | New York University | Use of glycosylceramides as adjuvants for vaccines against infections and cancer |
| EP1569515A4 (en) * | 2002-10-23 | 2006-04-26 | Glaxosmithkline Biolog Sa | MALARIA vaccine method |
| NZ539813A (en) * | 2002-12-17 | 2008-04-30 | Crucell Holland Bv | A replication defective recombinant adenovirus comprising a antigenic determinant of Plasmodium falciparum wherein the antigenic determinant is SEQ ID 6 |
| US7611868B2 (en) * | 2003-05-14 | 2009-11-03 | Instituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | Recombinant modified adenovirus fiber protein |
| JP2005287309A (ja) * | 2004-03-31 | 2005-10-20 | Dnavec Research Inc | 遺伝子導入を増強するための薬剤および方法 |
| CN101072879B (zh) * | 2004-10-13 | 2011-05-11 | 克鲁塞尔荷兰公司 | 改良的腺病毒载体及其应用 |
| WO2007027860A2 (en) * | 2005-08-31 | 2007-03-08 | Genvec, Inc. | Adenoviral vector-based malaria vaccines |
| WO2008140474A1 (en) * | 2006-10-26 | 2008-11-20 | Johns Hopkins University | Recombinant adenovirus vaccines |
-
2009
- 2009-08-18 WO PCT/US2009/054212 patent/WO2011022002A1/en not_active Ceased
-
2010
- 2010-08-18 SG SG10201404970PA patent/SG10201404970PA/en unknown
- 2010-08-18 CN CN201080047059.6A patent/CN103025349B/zh not_active Expired - Fee Related
- 2010-08-18 PH PH1/2012/500164A patent/PH12012500164A1/en unknown
- 2010-08-18 RU RU2012110255/10A patent/RU2585228C2/ru not_active IP Right Cessation
- 2010-08-18 WO PCT/US2010/045952 patent/WO2011022522A1/en not_active Ceased
- 2010-08-18 CA CA2769415A patent/CA2769415A1/en not_active Abandoned
- 2010-08-18 CN CN201510745347.3A patent/CN105770880A/zh active Pending
- 2010-08-18 SG SG2012011144A patent/SG178476A1/en unknown
- 2010-08-18 UA UAA201203125A patent/UA108081C2/ru unknown
- 2010-08-18 MX MX2012002131A patent/MX339830B/es active IP Right Grant
- 2010-08-18 EP EP10810576.8A patent/EP2467157A4/en not_active Withdrawn
- 2010-08-18 NZ NZ598703A patent/NZ598703A/en not_active IP Right Cessation
- 2010-08-18 JP JP2012525677A patent/JP5947719B2/ja not_active Expired - Fee Related
- 2010-08-18 BR BR112012003808A patent/BR112012003808A2/pt not_active IP Right Cessation
- 2010-08-18 EP EP18168155.2A patent/EP3412306A3/en not_active Withdrawn
- 2010-08-18 KR KR1020127006889A patent/KR20120094469A/ko not_active Ceased
-
2012
- 2012-01-24 IL IL217709A patent/IL217709A/en not_active IP Right Cessation
- 2012-02-21 ZA ZA2012/01286A patent/ZA201201286B/en unknown
-
2016
- 2016-03-03 JP JP2016041230A patent/JP6293181B2/ja not_active Expired - Fee Related
-
2017
- 2017-01-30 US US15/419,523 patent/US20170348405A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016146837A5 (enExample) | ||
| SG156535A1 (en) | Recombinant viral-based malaria vaccines | |
| IL214460A0 (en) | Malaria prime/boost vaccines | |
| UA108081C2 (uk) | Модифікація рекомбінантного аденовірусу імуногенними епітопами білка circumsporozoite плазмодія | |
| RU2015135890A (ru) | Композиция вакцины | |
| MX2020000221A (es) | Secuencias de aminoacidos y de acidos nucleicos de adenovirus de grandes simios no humanos, vectores que contienen las mismas y usos de las mismas. | |
| JP2008529558A5 (enExample) | ||
| JP2016539946A5 (enExample) | ||
| JP2019519252A5 (enExample) | ||
| EA200901060A1 (ru) | Новый способ и композиции | |
| JP2015096070A5 (enExample) | ||
| JP2013507907A5 (enExample) | ||
| WO2011138251A8 (en) | Lentiviral vector based immunological compounds against malaria | |
| JP2020536489A5 (enExample) | ||
| JP2014507146A5 (enExample) | ||
| WO2014205579A4 (en) | Modified matrix proteins of vesicular stomatitis virus | |
| Radošević et al. | The Th1 immune response to Plasmodium falciparum circumsporozoite protein is boosted by adenovirus vectors 35 and 26 with a homologous insert | |
| Schöne et al. | Immunodominance of adenovirus-derived CD8+ T cell epitopes interferes with the induction of transgene-specific immunity in adenovirus-based immunization | |
| JP2014519817A5 (enExample) | ||
| ZA201707985B (en) | Recombinant modified vaccinia virus ankara (mva) foot and mouth disease virus (fmdv) vaccine | |
| Holanda et al. | Recombinant vaccines of a CD4+ T-cell epitope promote efficient control of Paracoccidioides brasiliensis burden by restraining primary organ infection | |
| JP2020509770A5 (enExample) | ||
| WO2008086386A8 (en) | Adenoviral vector-based malaria vaccines | |
| JP2018533908A5 (enExample) | ||
| PH12018502430A1 (en) | Vaccines |